08.11.2018 08:00:02
|
DGAP-News: CompuGroup Medical SE announces results for third quarter of 2018
DGAP-News: CompuGroup Medical SE / Key word(s): Quarter Results Koblenz, November 08th, 2018 - CompuGroup Medical SE (CGM) today announced its financial report for the third quarter of 2018. With a turnover of EUR 166 million, the company could achieve organic growth of 20 percent compared to the same period last year (EUR 138 million). EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to EUR 37 million compared to EUR 28 million in the third quarter of 2017, with the operating margin rising from 20 to 22 percent. This applies not only to the information systems with which we support the health professionals in doctors' and dentists' offices, pharmacies, hospitals, laboratories, nursing homes, and many more in their important work on a daily basis. It particularly applies to the solutions for networking these systems, so that the health professionals can optimally accompany their entrusted people on their patient journeys. Last but not least, it applies to the electronic health records; With their help, everyone can jointly and effectively benefit from the best care. We have accepted this effort, as well as the responsibility, to a great extent, in order to further develop the overdue networking of those involved in the provision of healthcare. Thus, the work on our ambitious goal - the introduction of the telematics infrastructure (TI) - is proceeding according to plan. Together with our partners, our dedicated employees prove on a daily basis that it is possible to reliably connect every doctor - whether in the doctor's or dental office or in the hospital - to the TI, regardless of the information system used. We are firmly convinced that in this way we are making a significant contribution to supporting the introduction of the electronic health record (eHR) and to putting healthcare in Germany at the appropriate top position, also with regard to digital health." CompuGroup Medical confirms the forecast for the 2018 fiscal year published in its 2017 annual report. The company expects consolidated revenues of between EUR 700 million and EUR 730 million and consolidated operating earnings (EBITDA) of between EUR 175 million and EUR 190 million. To participate in the conference call, please dial one of the following telephone numbers and enter the participation code: +49 (0) 69 2 22 22 90 43 (Germany) A presentation will be available at http://www.cgm.com at the beginning of the conference call. You can follow the presentation live here (https://webcasts.eqs.com/compugroup20181108/no-audio).
CompuGroup Medical SE
08.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | CompuGroup Medical SE |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)261 8000 6200 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE0005437305 |
WKN: | 543730 |
Indices: | SDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |
|
742987 08.11.2018
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!